DUBLIN--(BUSINESS WIRE)--The "Ethylbenzene Industry Outlook in India to 2026 - Market Size, Company Share, Price Trends, Capacity Forecasts of All...
BARCELONA, Spain--(BUSINESS WIRE)--During the Huawei Day 0 Forum at MWC Barcelona 2022, Huawei released a series of new IT products...
DUBLIN--(BUSINESS WIRE)--The "China B2C E-Commerce Market 2022" report has been added to ResearchAndMarkets.com's offering. China accounts for more than half...
Five finalist teams advance in the $5M XPRIZE Rapid Reskilling competition to quickly reskill under-resourced workers for the digital revolution....
Company taps QSR sector veteran Ignacio Barbadillo who joins as Director of International New Business Development ATLANTA--(BUSINESS WIRE)--Texas Chicken™ and...
MELBOURNE, Australia & NEW YORK--(BUSINESS WIRE)--Immediation, a leading digital legal environment provider, and the International Institute for Conflict Prevention &...
TOKYO & BOTHELL, Wash.--(BUSINESS WIRE)--Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seagen Inc. (Nasdaq:SGEN) today...
DENVER--(BUSINESS WIRE)--Gold Resource Corporation (NYSE American: GORO) (the “Company”) announced today that the Company will host a conference call on...
Key Points: Founding partners Luke Alvarez, Cherry Freeman and Sir Ian Livingstone launch their second VC fund ($340m) in three...
First Korean content platform to become a unicorn startup with an enterprise value of KRW 1.6 trillion Demonstrated global competitiveness...
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.--(BUSINESS WIRE)--#CRCSM--Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical-stage biopharmaceutical company dedicated to discovering and...
To leverage world-leading network and infrastructure capabilities in partnership with hyper-scalers and startups to build B2B use cases across sectors...
Jefferies Calls on Wall Street and Investors Around the World to Stand Together for Freedom and Support the People of...
Alvotech is the only known company to have both developed a high-concentration biosimilar to Humira and conducted a switching study...
? Interim Real-World Data from Phase 4 EMPOWER Study Show Attack Rate Reduction and Improvement in Treatment Satisfaction and Other...
